CAS 2990472-61-0

1H-Pyrazole-3-carboxamide, 1-(4-fluorophenyl)-N-[(3S)-1-pyrrolo[1,2-a]pyrazin-1-yl-3-pyrrolidinyl]-, hydrochloride (1:1)

Description:

1H-Pyrazole-3-carboxamide, 1-(4-fluorophenyl)-N-[(3S)-1-pyrrolo[1,2-a]pyrazin-1-yl-3-pyrrolidinyl]-, hydrochloride (1:1) is a complex organic compound characterized by its pyrazole and pyrrolidine moieties, which contribute to its potential biological activity. The presence of a fluorophenyl group suggests enhanced lipophilicity and possibly improved pharmacokinetic properties. As a hydrochloride salt, it is likely to exhibit increased solubility in aqueous environments, making it suitable for various formulations. The compound's structure indicates potential interactions with biological targets, which may be relevant in medicinal chemistry, particularly in the development of pharmaceuticals. Its specific stereochemistry, denoted by the (3S) configuration, may influence its biological activity and receptor interactions. Overall, this compound's unique structural features position it as a candidate for further investigation in drug discovery and development, particularly in areas related to neuropharmacology or oncology, although detailed biological activity and safety profiles would require empirical studies.

Formula: C₂₁H₁₉FN₆O·ClH

Synonyms:

• 1H-Pyrazole-3-carboxamide, 1-(4-fluorophenyl)-N-[(3S)-1-pyrrolo[1,2-a]pyrazin-1-yl-3-pyrrolidinyl]-, hydrochloride (1:1)

CXCR7 antagonist-1 hydrochloride

CAS: 2990472-61-0

CXCR7 antagonist-1 hydrochloride, Inhibits SDF-1 (CXCL12) or I-TAC binding to CXCR7, used for tumor and inflammation research.

Formula: C₂₁H₂₀ClFN₆O

Purity: 99.84%

Color and Shape: Solid

Molecular weight: 426.87

Ref: TM-T62325